Early gut microbiota intervention in premature infants: Application perspectives

Quanhang Xiang1, Xudong Yan2, Wei Shi3

  • 1Shenzhen Institute of Respiratory Diseases, the Second Clinical Medical College, Jinan University (Shenzhen People's Hospital), Shenzhen, China.

Insights

Premature infants often have gut microbiota dysbiosis, impacting immune system development. Early interventions like probiotics can improve gut health and immunity, but require further study for optimal use.

Area of Science:

  • Neonatal immunology
  • Microbiome research
  • Gastroenterology

Background:

  • Preterm birth is a leading cause of infant mortality, with incomplete intestinal immune development posing significant risks.
  • The gut microbiota is crucial for intestinal immune system development, but premature infants are prone to dysbiosis, negatively affecting immune education.
  • Gut microbiota dysbiosis in premature infants is linked to adverse immune system development and increased disease risk.

Purpose of the Study:

  • To review the characterization and mechanisms of gut microbiota and intestinal immunity in premature infants.
  • To discuss the current status, safety, applicability, and future prospects of early intervention strategies for premature infants.
  • To provide an overview of applications and identify knowledge gaps in early interventions for premature infant gut health.

Main Methods:

  • Literature review of studies on gut microbiota and intestinal immunity in premature infants.
  • Analysis of early intervention strategies, including probiotics, fecal microbiota transplantation, and nutritional support.
  • Synthesis of evidence on the impact of interventions on gut microbiota colonization and immune development.

Main Results:

  • Premature infants exhibit high-risk gut microbiota dysbiosis, leading to impaired intestinal immune function.
  • Early interventions demonstrate potential in improving the intestinal environment and promoting beneficial gut microbiota colonization.
  • Various interventions (probiotics, FMT, nutrients) show differing safety profiles, applicability, and outcomes, with complex and incompletely understood mechanisms.

Conclusions:

  • Gut microbiota dysbiosis is a critical issue in premature infants, impacting immune development.
  • Early interventions are vital for modulating gut microbiota and enhancing intestinal immunity in this vulnerable population.
  • Further research is needed to elucidate the mechanisms and optimize the application of diverse early intervention strategies for premature infants.
Abstract